CHD1L and hepatocellular carcinoma: Recently, intensive evidence demonstrated that CHD1L was highly expressed in most types of malignancy, like hepatocellular carcinoma (HCC), breast cancer, lung cancer, ovarian cancer, or colon cancer [19, 20].